Comerica Bank Meridian Bioscience Inc Transaction History

Comerica Bank

  • $25 Billion
  • Q3 2024

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 26, 2023
SELL
$31.15 - $33.39 $228,267 - $244,681
-7,328 Reduced 21.88%
26,158 $0
Q3 2022

Oct 28, 2022
SELL
$30.9 - $33.55 $115,009 - $124,873
-3,722 Reduced 10.0%
33,486 $1.07 Million
Q2 2022

Aug 02, 2022
SELL
$23.75 - $31.69 $4,156 - $5,545
-175 Reduced 0.47%
37,208 $1.21 Million
Q1 2022

Apr 27, 2022
SELL
$19.97 - $26.94 $4,493 - $6,061
-225 Reduced 0.6%
37,383 $970,000
Q4 2021

Feb 18, 2022
SELL
$17.46 - $21.61 $30,642 - $37,925
-1,755 Reduced 4.46%
37,608 $767,000
Q3 2021

Nov 22, 2021
SELL
$17.35 - $22.5 $19,310 - $25,042
-1,113 Reduced 2.75%
39,363 $757,000
Q2 2021

Aug 26, 2021
SELL
$18.01 - $28.32 $55,650 - $87,508
-3,090 Reduced 7.09%
40,476 $897,000
Q1 2021

Apr 28, 2021
SELL
$19.76 - $29.89 $30,015 - $45,402
-1,519 Reduced 3.37%
43,566 $1.14 Million
Q4 2020

Jan 28, 2021
BUY
$15.73 - $21.66 $1,573 - $2,166
100 Added 0.22%
45,085 $842,000
Q3 2020

Oct 30, 2020
SELL
$13.54 - $26.41 $1,760 - $3,433
-130 Reduced 0.29%
44,985 $763,000
Q2 2020

Jul 31, 2020
BUY
$7.84 - $23.29 $29,298 - $87,034
3,737 Added 9.03%
45,115 $1.05 Million
Q1 2020

May 01, 2020
BUY
$5.57 - $11.5 $9,017 - $18,618
1,619 Added 4.07%
41,378 $347,000
Q4 2019

Feb 07, 2020
SELL
$7.9 - $10.14 $1,832 - $2,352
-232 Reduced 0.58%
39,759 $388,000
Q3 2019

Oct 31, 2019
BUY
$9.17 - $12.01 $7,546 - $9,884
823 Added 2.1%
39,991 $379,000
Q2 2019

Aug 02, 2019
SELL
$10.88 - $17.6 $35,381 - $57,235
-3,252 Reduced 7.67%
39,168 $0
Q1 2019

May 02, 2019
BUY
$15.51 - $17.61 $14,532 - $16,500
937 Added 2.26%
42,420 $0
Q4 2018

Feb 06, 2019
BUY
$14.52 - $19.72 $5,212 - $7,079
359 Added 0.87%
41,483 $667,000
Q3 2018

Nov 01, 2018
SELL
$14.85 - $16.35 $52,984 - $58,336
-3,568 Reduced 7.98%
41,124 $645,000
Q2 2018

Aug 01, 2018
BUY
$13.8 - $16.8 $7,617 - $9,273
552 Added 1.25%
44,692 $706,000
Q1 2018

May 01, 2018
BUY
$13.8 - $16.2 $10,902 - $12,798
790 Added 1.82%
44,140 $651,000
Q4 2017

Feb 02, 2018
SELL
$13.55 - $15.8 $16,110 - $18,786
-1,189 Reduced 2.67%
43,350 $642,000
Q3 2017

Nov 06, 2017
BUY
$13.45 - $14.35 $599,049 - $639,134
44,539
44,539 $655,000

Others Institutions Holding VIVO

# of Institutions
10
Shares Held
113K
Call Options Held
0
Put Options Held
0
View Full List

About MERIDIAN BIOSCIENCE INC

VIVO Quotes by TradingView
  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Comerica Bank Portfolio

Follow Comerica Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email